Does Rallies show 13F holders for ENTA?

Yes. Rallies tracks hedge fund and 13F ownership data for ENTA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ENTA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENTA. It does not provide personalized investment advice.

ENTA (Enanta Pharmaceuticals, Inc) Stock Analysis - Hedge Fund Holdings

Enanta Pharmaceuticals, Inc (ENTA) is a publicly traded Healthcare sector company. As of May 21, 2026, ENTA trades at $9.48 with a market cap of $391.10M and a P/E ratio of -5.28. ENTA moved -0.87% today. Year to date, ENTA is -2.16%; over the trailing twelve months it is +124.22%. Its 52-week range spans $4.09 to $17.15. Analyst consensus is strong buy with an average price target of $19.67. Rallies surfaces ENTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ENTA stock?

Hedge funds tracked by Rallies that own ENTA include Farallon Capital and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Enanta Pharmaceuticals, Inc.

ENTA Key Metrics

Key financial metrics for ENTA
Metric	Value
Price	$9.48
Market Cap	$391.10M
P/E Ratio	-5.28
EPS	$-2.60
Dividend Yield	0.00%
52-Week High	$17.15
52-Week Low	$4.09
Volume	2
Avg Volume	0
Revenue (TTM)	$69.21M
Net Income	$-61.98M
Gross Margin	0.00%

Top Hedge Funds Holding ENTA

Farallon Capital holds 2.87M shares of ENTA, changed +3.59% as of Mar 31, 2026.
Panagora Asset holds 89.60K shares of ENTA, changed +33.75% as of Mar 31, 2026.

Latest ENTA News

Enanta Pharmaceuticals Posts Q2 Loss of $0.45, Shares Jump 5.3% — May 11, 2026
Enanta to Present Phase 2b RSV Trial Showing One-Week Symptom Reduction and Resistance Barrier — Apr 7, 2026
Enanta Posts Q1 $0.42 Loss per Share, Beats Revenue by 19.5% — Feb 9, 2026

Recent ENTA Insider Trades

Capps Kathleen S. sold 323 (~$4.60K) on Dec 5, 2025.
Trout Harry R. III sold 542 (~$7.71K) on Dec 5, 2025.
Rottinghaus Scott T. sold 798 (~$11.36K) on Dec 5, 2025.

ENTA Analyst Consensus

3 analysts cover ENTA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.67.

Common questions about ENTA

Who owns ENTA stock?: Hedge funds tracked by Rallies that own ENTA include Farallon Capital and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Enanta Pharmaceuticals, Inc.
Does Rallies show 13F holders for ENTA?: Yes. Rallies tracks hedge fund and 13F ownership data for ENTA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ENTA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENTA. It does not provide personalized investment advice.